Sanam Shahid

8PUBLICATIONS
48CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Technology, crime and surveillanceBiomedical instrumentationHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 11, 2025
Systematic Evaluation of GAPs and GEFs Identifies a Targetable Dependency for Hematopoietic Malignancies.

Pu Zhang, Zhendong Cao, Xiangyu Pan

|Feb 05, 2025
Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies.

Sanam Shahid, Susan E Prockop, Georgia C Flynn

|Jan 17, 2025
Predicting CAR T-cell toxicity: insurance for CAR crashes.

Sanam Shahid, Kevin J Curran

|Aug 30, 2024
Engineered NKG2C + NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndrome.

Kyle B Lupo, M Kazim Panjwani, Sanam Shahid

|May 21, 2024
Developing a membrane-proximal CD33-targeting CAR T cell.

Ruby Freeman, Sanam Shahid, Abdul G Khan

|Jun 16, 2023
Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia.

Sanam Shahid, Nicholas Ceglia, Jean-Benoît Le Luduec

Pageof 2

Frequent Collaborators

3 joint publications

Anthony F Daniyan

2 joint publications

M Kazim Panjwani

2 joint publications

Omar Abdel-Wahab

2 joint publications

Katharine C Hsu